SPOTLIGHT: Biotech start-up begins building

BioConvergence, a start-up biotech company, is preparing to break ground on a $14 million facility in Bloomington, Indiana, and create 170 jobs over the next five years. Article

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.